Drug Trial Radar · NCT00441545
Head to Head Study Against Sevelamer Hydrochloride
Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
182
Actual
Start
Jan 5, 2007
Primary completion
Jul 31, 2008
Study completion Jul 31, 2008
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Mar 1, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline.
Conditions
- Chronic Kidney Disease, Stage 5
Interventions
Fosrenol (Lanthanum Carbonate)Drug
The starting dose is a total daily dose of 2250mg of Fosrenol (Lanthanum carbonate) to a maximum dose of 3000mg daily. Chewable tablets will be administered orally with meals in 750mg and 1000mg strength tablets.
Sevelamer hydrochlorideDrug
The starting dose is a total daily dose of 4800mg of sevelamer hydrochloride up to a maximum of 6400 mg daily. Sevelamer hydrochloride 800mg tablets, administered orally with meals.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Serum Phosphorus Levels at 4 WeeksTime frame: 4 weeks
Locations
44 sites in 4 countries. Site status is shown where the registry gives one.
DSI Renal Inc.
Mesa, Arizona
AKDHC Medical Research Services, LLC
Phoenix, Arizona
Southwest Kidney Institute, PLC
Tempe, Arizona
Site not named
Tempe, Arizona
University of Arizona Health Service Center
Tucson, Arizona
Clinical Research Connections
Jonesboro, Arkansas
South Valley Dialysis Center
Encino, California
VA Greater Los Angeles Health Care System, West LA
Los Angeles, California
Apex Research of Riverside
Riverside, California
North Valley Nephrology
Yuba City, California
Western Nephrology & Metabolic Bone Disease, PC
Thornton, Colorado
Shands University of Florida Outpatient Dialysis
Gainesville, Florida
Discovery Medical Research Group
Ocala, Florida
Pines Clinical Research
Pembroke Pines, Florida
Clinical Research Center of Indian River Medical Center
Vero Beach, Florida
Kidney Care Associates, LLC
Augusta, Georgia
Renal Physicians of Georgia
Macon, Georgia
Evanston Northwestern Hospital
Evanston, Illinois
Research by Design, LLC
Evergreen Park, Illinois
Nephrology Inc.
Mishawaka, Indiana
Renal Associates of Baton Rouge
Baton Rouge, Louisiana
Creighton University Medical Center
Omaha, Nebraska
Hypertension and Nephrology, Associates
Eatontown, New Jersey
Winthrop Dialysis Center
Mineola, New York
SUNY at Stony Brook NY
Stony Brook, New York
Wake Nephrology Associates
Raleigh, North Carolina
Southeastern Nephrology Associates
Wilmington, North Carolina
Northwest Renal Clinic
Portland, Oregon
Carolina Nephrology, PA
Greenville, South Carolina
VA Tennessee Valley Healthcare System
Nashville, Tennessee
Rosa Verde Tower
San Antonio, Texas
University of Texas Health Science Center at San Antonio Medicine/Nephrology
San Antonio, Texas
Alexandria Kidney
Alexandria, Virginia
Clinical Research & Consulting Center, LLC
Fairfax, Virginia
KfH Nierenzentrum/Bad/Konig
Bad König, Germany
KfH Nierenzentrum
Berlin, Germany
KfH Dialysezentrum/Berlin
Berlin, Germany
KfH Nierenzentrum/Dulmen
Dülmen, Germany
Georg-August-Universitat Universitatsmedizin Abt. Nephrologie u. Rheumatologie
Göttingen, Germany
Dialysezentrum Barmbeck
Hamburg, Germany
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.